Voyager Therapeutics to Participate in Upcoming Investor Conferences

Voyager Therapeutics to Participate in Upcoming Investor Conferences




Voyager Therapeutics to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy company developing life-changing treatments and next-generation platform technologies, today announced that it will participate in the following upcoming virtual investor conferences.

  • Wedbush PacGrow Healthcare Conference, panel discussion, August 11, 2021, 8:35 AM ET.
  • Canaccord Genuity Growth Conference, fireside chat, August 12, 2021, 10:30-10:55 AM ET.

The sessions may be accessed from the Investors & Media section of Voyager’s website at www.voyagertherapeutics.com. Replays of the webcasts will be archived on the Company’s website for at least 30 days.

About Voyager Therapeutics
Voyager Therapeutics (Nasdaq: VYGR) is leading the next generation of AAV gene therapy to unlock the potential of the technology to treat devastating diseases. Proprietary capsids born from the Company’s TRACER™ screening platform are powering a rich early-stage pipeline of new and second-generation programs and may elevate the field to overcome the limitations of conventional gene therapy vectors across neurological disorders and other therapeutic areas.

voyagertherapeutics.com LinkedIn Twitter

Investor Inquiries:        
investors@voyagertherapeutics.com

Media Inquiries:        
Scott Santiamo
ssantiamo@voyagertherapeutics.com